/Investor DB

Wellcome Trust

Foundation

London · Series B–Late Stage

Find your way into Wellcome Trust

Sign up to see every warm intro you have to Wellcome Trust

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Wellcome Trust team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

✨ Fox Verdict
Sign up to see your fit
Stage
Series B–Late Stage
HQ
London, GB
Instruments
Grants
Founded
1992
Last 12 months
1 investment
Tracked investments
15
Unicorns
3
IPOs
2
Acquisitions
2

Founder mafia

4 people who came through Wellcome Trust went on to found or lead other companies.

What they invest in

from 12 of 15 portfolio companies

Biotech ×5Healthtech ×4Medical Devices ×4Consumer ×3Deep Tech ×3E-commerce ×2Energy ×2FoodTech ×2

HQs:United States×9France×1United Kingdom×1

Investments · 15 tracked

founders shown can be your intro path

By year:2026 · 12019 · 22018 · 12017 · 12016 · 22015 · 12007 · 19 dated

DoorDashdoordash.comin𝕏NASDAQ: DASHSeries C · Mar 2018 · $535M

DoorDash operates a restaurant delivery platform that connects customers with dining establishments across hundreds of cities in North America through a logistics network.

ConsumerE-commerceFoodTechLogistics & Supply ChainMarketplacesSan Francisco, US

Tony Xu(CEO)inAndy Fang(Founder)inStanley Tang(Founder)inEvan Moore(Founder)inRavi Inukonda(Chief Financial Officer)inPrabir Adarkar(Chief Operating Officer and President)in

Co-investorsA*Blue Owl CapitalBoxGroupBrave CapitalCoatue ManagementCRV (Charles River Ventures)+38 more

Instacartinstacart.comin𝕏NASDAQ: CARTLate Stage

Instacart operates a marketplace connecting grocery retailers with customers who order food and household items for same-day delivery or in-store pickup, serving millions of households across North America through partnerships with over 350 retailers.

ConsumerE-commerceFoodTechSan Francisco, US

Apoorva Mehta(Chairman \u0026 Founding CEO)inBrandon Leonardo(Founder)inMax Mullen(Founder)inChris Rogers(Chief Executive Officer)inEmily Reuter(Chief Financial Officer)inHetong Li(Senior Software Engineer)

Co-investorsA*Andreessen HorowitzAvenue Growth PartnersBACKGROUND CAPITALBling CapitalBright Pixel Capital+54 more

Corinnovacorinnova.cominJun 2017✓ verified

CorInnova develops a minimally invasive, non-blood contacting cardiac assist device designed to treat acute heart failure patients who cannot use existing solutions.

Deep TechHealthtechMedical DevicesHouston, US

John Criscione(Director)inWilliam Altman(Executive Officer, Director)inDennis Robins(Director)Boris Leschinsky(Executive Officer)Clarice Motter(Executive Officer)Keith Svagerko(Executive Officer)

Co-investorsCowtown AngelsHouston Angel NetworkKeiretsu ForumTMC Venture FundHarvard Business School Alumni Angels of Greater New YorkAggie Angel Network+1 more

Exonate - companyexonate.comin𝕏✓ verified

Exonate is a biotechnology company developing treatments for retinal vascular diseases, with a lead asset (EXN407) intended as a topical therapy for diabetic retinopathy and diabetic macular oedema.

BiotechDigital HealthHealthtechMedical Devices

Olav Hellebø(Chief Executive Officer)in

Co-investorsO2h VenturesWren CapitalCambridge Angels groupEMV CapitalMartlet CapitalStoic VC+1 more

Omnioxomniox.com✓ verified

Omniox is an IND-stage biotechnology company developing OMX oxygen-delivery vehicles based on its H-NOX platform technology to treat medical conditions where tissue hypoxia drives disease.

BiotechMedical DevicesSan Francisco, US

Jonathan Winger(Co-Founder & CEO)inStephen Cary(Executive Officer, Director)

BoardJeffrey S. Samberg(Director)Laurence Marton(Director)Mitchell Mutz(Director)John Wesley(Director)

Co-investorsEcoR1 CapitalPlug and Play VenturesWavemaker Three-Sixty Health

Osivaxosivax.comin𝕏✓ verified

Osivax develops vaccines targeting conserved internal viral structures to provide broader and longer-lasting protection against influenza, leveraging its proprietary oligoDOM technology platform.

BiotechHealthtechMedical DevicesLyon, FR

Alexandre Le Vert(Executive Chairman & Co-Founder)inDr Florence Nicolas(Chief Scientific Officer & Co-Founder)Dr Fergal Hill(Co-founder)

Co-investorsStart CapitalCAP HORN VC

Tri Alpha Energytae.comin𝕏✓ verified

TAE Technologies develops hydrogen-boron (aneutronic) fusion power using a beam-driven Field-Reversed Configuration reactor design, aiming to deliver utility-scale fusion electricity to the grid in the early 2030s.

CleantechDeep TechEnergyFoothill Ranch, US

Norman Rostoker(Founder)Michl Binderbauer(Founder)inCedric Burgher(Chief Financial Officer)in

Co-investorsNew Enterprise Associates (NEA)Chevron Technology VenturesCapital FactoryUpVentures CapitalVenrockFor Good Ventures+1 more

Ineffable Intelligenceineffable.aiin𝕏Apr 2026

Ineffable is an AI research lab focused on building superintelligence through the reinforcement learning paradigm, emphasizing learning from experience in the environment rather than from human data.

AI & Machine LearningDeep TechLondon, GB

David Silver(Founder)inAlexandre Laterre(Co-Founder)inChris Apps(Founder)in

BoardAlfred Lin(Director (Sequoia Capital))inRavi Mhatre(Director (Lightspeed))in

Co-investorsBond Capital ManagementEQT VenturesFlying Fish VenturesIndex VenturesLightspeed Venture PartnersSequoia Capital+7 more

Karunatxkarunatx.comApr 2019Acquired

Karuna Therapeutics is a Boston neuroscience biopharma behind muscarinic drug KarXT, acquired by Bristol Myers Squibb in 2024.

Co-investorsARCH Venture PartnersPivotal Life SciencesSofinnova VenturesAlexandriaPureTech Health

Kinetakinetabio.comAug 2019 · $1.8M

BiotechSeattle, US

Shawn Iadonato(Executive Officer, Director)inRobert Hedequist(Executive Officer)Pauline Kenny(Executive Officer)inCharles Magness(Director)

Co-investorsKeiretsu ForumPfizer Venture InvestmentsTSVC

Lumos Pharmalumos-pharma.comin𝕏Apr 2016

Lumos Pharma is a clinical-stage biopharmaceutical company developing therapies for rare diseases, with a lead candidate targeting Pediatric Growth Hormone Deficiency.

BiotechHealthtechAustin, US

Richard John Hawkins(Executive Officer, Director)John C. McKew(President and Chief Scientific Officer)inPisit "Duke" Pitukcheewanont(Chief Medical Officer)inLori Lawley(Chief Financial Officer)inBrad Powers(Chief Compliance Officer and General Counsel)inCampbell Murray(Executive Chairman)in

Co-investorsNew Enterprise Associates (NEA)Clarus VenturesDeerfield Management CompanySante Health VenturesSante Ventures

ReViralreviral.co.uk

Reviral operates an affiliate review site that ranks and reviews online casinos not registered with the UK's GamStop self-exclusion scheme, comparing licences, bonuses, wagering terms, payout speeds, and payment methods.

ConsumerMedia & Entertainment

Co-investorsAndera PartnersBrace PharmaNew Leaf Venture PartnersOrbiMed

Xtera CommunicationsinAug 2007Acquired

Subsea and terrestrial optical transport supplier whose assets, rescued by H.I.G. in 2017, are being bought by Prysmian and Fincantieri.

Allen, US

Keith Henderson(Executive Officer)inLes Barkley(Executive Officer)inPaul Colan(Executive Officer)inJon Hopper(Executive Officer, Director)inGary Otake(Executive Officer)inHerve Fevrier(Executive Officer)

Co-investorsARCH Venture PartnersAristos VenturesNew Enterprise Associates (NEA)

Other

Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.

ArrayjetSapphire Energy

Exits · 4

2 IPOs · 2 acquisitions · showing 2

DoorDashNASDAQ: DASHInstacartNASDAQ: CART

Portfolio news

latest coverage across their companies

Principals & officers · per Companies House

what is this? ⓘ
Christopher Bird

Secretary · since 2016

Julia Eileen Gillard

Director · Australian · since 2021

Richard Dunnell Gillingwater

Director · British · since 2019

Gabriel Matthew Professor Leung

Director · Chinese · since 2021

Stephen Augustus Lovegrove

Director · British · since 2023

Diana Georgina Noble

Director · British · since 2023

Fiona Professor Powrie

Director · United Kingdom · since 2018

Cilla Dame Snowball

Director · British · since 2019

Elhadji Amadou Gueye Sy

Director · Senegalese · since 2020

Ijeoma Florence Professor Uchegbu

Director · British · since 2021

Frequently asked questions

How many investments has Wellcome Trust made?
Wellcome Trust has 15 tracked investments, 4 of which have exited, including 1 dated in the last 24 months.
What stage does Wellcome Trust invest at?
Wellcome Trust invests at the Series B, Series C, Growth, Late Stage stages.
What sectors does Wellcome Trust focus on?
Wellcome Trust focuses on Biotech, Healthtech, IoT, Medical Devices.
Where is Wellcome Trust located?
Wellcome Trust is headquartered in London, GB.

Similar investors

Featured in lists